Citations

Mayo Clinic

Showing 10 of 108599 citations.

Randomized Clinical Trial of a Combination of an Inhaled Corticosteroid and Beta Agonist in Patients at Risk of Developing the Acute Respiratory Distress Syndrome*
Festić, Emir , Carr, Gordon, Cartin‐Ceba, Rodrigo , Hinds, Richard , Banner‐Goodspeed, Valerie , Bansal, Vikas , Asuni, Adijat T., Talmor, Daniel , Rajagopalan, Govindarajan, Frank, Ryan D. , Matthay, Michael A. , Levitt, Joseph E. , Asuni, Adijat, Gajic, Ognjen , Bansal, Vikas

Critical Care Medicine | February 25, 2017 | Volume: 45 | Issue: 5 | Pages: 798-805

10.1097/ccm.0000000000002284 | PMID 28240689 Get It

Objectives: Effective pharmacologic treatments directly targeting lung injury in patients with the acute respiratory distress syndrome are lacking. Early treatment with inhaled corticosteroids and beta agonists may reduce progression to acute respiratory distress syndrome by reducing lung inflammation and enhancing alveolar fluid clearance. Design: Double-blind, randomized clinical trial (ClinicalTrials.gov: NCT01783821). The primary outcome was longitudinal change in oxygen saturation divided by the F io 2 (S/F) through day 5. We also analyzed categorical change in S/F by greater than 20%. Other outcomes included need for mechanical ventilation and development of acute respiratory distress syndrome. Setting: Five academic centers in the United States. Patients: Adult patients admitted through the emergency department at risk for acute respiratory distress syndrome. Interventions: Aerosolized budesonide/formoterol versus placebo bid for up to 5 days. Measurements and Main Results: Sixty-one patients were enrolled from September 3, 2013, to June 9, 2015. Median time from presentation to first study drug was less than 9 hours. More patients in the control group had shock at enrollment (14 vs 3 patients). The longitudinal increase in S/F was greater in the treatment group ( p = 0.02) and independent of shock ( p = 0.04). Categorical change in S/F improved ( p = 0.01) but not after adjustment for shock ( p = 0.15). More patients in the placebo group developed acute respiratory distress syndrome (7 vs 0) and required mechanical ventilation (53% vs 21%). Conclusions: Early treatment with inhaled budesonide/formoterol in patients at risk for acute respiratory distress syndrome is feasible and improved oxygenation as assessed by S/F. These results support further study to test the efficacy of inhaled corticosteroids and beta agonists for prevention of acute respiratory distress syndrome.
Cardiac MR elastography for quantitative assessment of elevated myocardial stiffness in cardiac amyloidosis
Arani, Arvin , Arunachalam, Shivaram P. , Chang, Ian C , Baffour, Francis , Rossman, Phillip J. , Glaser, Kevin J. , Trzasko, Joshua D. , McGee, Kiaran P. , Grogan, Martha , Dispenzieri, Angela , Araoz, Philip A. , Chang, Ian C Y, Manduca, Armando , Ehman, Richard L. , Dispenzieri, Angela , Arunachalam, S P , Arani, Arvin , Baffour, Francis I

Journal of Magnetic Resonance Imaging | February 25, 2017 | Volume: 46 | Issue: 5 | Pages: 1361-1367

10.1002/jmri.25678 | PMID 28236336 Get It

PurposeTo evaluate if cardiac magnetic resonance elastography (MRE) can measure increased stiffness in patients with cardiac amyloidosis. Myocardial tissue stiffness plays an important role in cardiac function. A noninvasive quantitative imaging technique capable of measuring myocardial stiffness could aid in disease diagnosis, therapy monitoring, and disease prognostic strategies. We recently developed a high‐frequency cardiac MRE technique capable of making noninvasive stiffness measurements.Materials and MethodsIn all, 16 volunteers and 22 patients with cardiac amyloidosis were enrolled in this study after Institutional Review Board approval and obtaining formal written consent. All subjects were imaged head‐first in the supine position in a 1.5T closed‐bore MR imager. 3D MRE was performed using 5 mm isotropic resolution oblique short‐axis slices and a vibration frequency of 140 Hz to obtain global quantitativein vivoleft ventricular stiffness measurements. The median stiffness was compared between the two cohorts. An octahedral shear strain signal‐to‐noise ratio (OSS‐SNR) threshold of 1.17 was used to exclude exams with insufficient motion amplitude.ResultsFive volunteers and six patients had to be excluded from the study because they fell below the 1.17 OSS‐SNR threshold. The myocardial stiffness of cardiac amyloid patients (median: 11.4 kPa, min: 9.2, max: 15.7) was significantly higher (P = 0.0008) than normal controls (median: 8.2 kPa, min: 7.2, max: 11.8).ConclusionThis study demonstrates the feasibility of 3D high‐frequency cardiac MRE as a contrast‐agent‐free diagnostic imaging technique for cardiac amyloidosis.Level of Evidence:2Technical Efficacy:Stage 2J. Magn. Reson. Imaging 2017;46:1361–1367.
Measurement of cochlear length using the ‘A' value for cochlea basal diameter: A feasibility study
Deep, Nicholas L. , Howard, Brittany E. , Holbert, Sarah O., Hoxworth, Joseph M. , Barrs, David M., Hoxworth, Joseph M

Cochlear Implants International | February 25, 2017 | Volume: 18 | Issue: 4 | Pages: 226-229

10.1080/14670100.2017.1292689 | PMID 28235385 Get It

Variation in MS outcome
Weinshenker, Brian G. , Lucas, Robyn , Lucas, Robyn M, Weinshenker, Brian G

Neurology | February 25, 2017 | Volume: 88 | Issue: 13 | Pages: 1214-1215

10.1212/wnl.0000000000003776 | PMID 28235813 Get It

Can Electroencephalogram Detect Vasospasm Before We Do?
Gupta, Aman , Rahme, Rudy J. , Welz, Matthew E., Bendok, Bernard R.

Neurosurgery | February 24, 2017 | Volume: 80 | Issue: 5 | Pages: N22-N23

10.1093/neuros/nyx097 | PMID 28586484 Get It

Systems biology approach to late‐onset Alzheimer's disease genome‐wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments
Mukherjee, Shubhabrata , Russell, Joshua C., Carr, Daniel, Burgess, Jeremy D. , Allen, Mariet , Serie, Daniel, Boehme, Kevin L. , Fardo, David W. , Montine, Thomas J. , Ertekin‐Taner, Nilüfer , Crane, Paul K. , Serie, Daniel J, Kauwe, John S. K. , Naj, Adam Christian , Dickson, Dennis W. , Kaeberlein, Matt R.

Alzheimer's & Dementia | February 24, 2017 | Volume: 13 | Issue: 10 | Pages: 1133-1142

10.1016/j.jalz.2017.01.016 | PMID 28242297 Get It

Abstract Introduction We sought to determine whether a systems biology approach may identify novel late‐onset Alzheimer's disease (LOAD) loci. Methods We performed gene‐wide association analyses and integrated results with human protein‐protein interaction data using network analyses. We performed functional validation on novel genes using a transgenic Caenorhabditis elegans Aβ proteotoxicity model and evaluated novel genes using brain expression data from people with LOAD and other neurodegenerative conditions. Results We identified 13 novel candidate LOAD genes outside chromosome 19. Of those, RNA interference knockdowns of the C. elegans orthologs of UBC, NDUFS3, EGR1 , and ATP5H were associated with Aβ toxicity, and NDUFS3, SLC25A11, ATP5H , and APP were differentially expressed in the temporal cortex. Discussion Network analyses identified novel LOAD candidate genes. We demonstrated a functional role for four of these in a C. elegans model and found enrichment of differentially expressed genes in the temporal cortex.
Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy
Sugrue, Alan , Killu, Ammar M. , Chahal, C. Anwar A. , Vogt, J., Křemen, Václav , Hai, Jo Jo , Hodge, David O. , Acker, Nancy G., Geske, Jeffrey B. , Ackerman, Michael J. , Ommen, Steve R. , Lin, Grace , Brady, Peter A. , Chahal, Anwar A, Vogt, Josh C, Hai, JoJo, DeSimone, Christopher V. , Noseworthy, Peter A. , Chahal, Choudhary Anwar A , Kremen, Vaclav , Geske, Jeffrey B

Open Heart | February 24, 2017 | Volume: 4 | Issue: 1 | Pages: e000561

10.1136/openhrt-2016-000561 | PMID 28409011 Get It

Objective Sudden cardiac arrest (SCA) is the most devastating outcome in hypertrophic cardiomyopathy (HCM). We evaluated repolarisation features on the surface electrocardiogram (ECG) to identify the potential risk factors for SCA. Methods Data was collected from 52 patients with HCM who underwent implantable cardioverter defibrillator (ICD) implantation. Leads V2 and V5 from the ECG closest to the time of ICD implant were utilised for measuring the Tpeak-Tend interval (Tpe), QTc, Tpe/QTc, T-wave duration and T-wave amplitude. The presence of the five traditional SCA-associated risk factors was assessed, as well as the HCM risk-SCD score. Results 16 (30%) patients experienced aborted cardiac arrest over 8.5±4.1 years, with 9 receiving an ICD shock and 7 receiving ATP. On univariate analysis, T-wave amplitude was associated with appropriate ICD therapy (HR per 0.1 mV 0.79, 95% CI 0.56 to 0.96, p=0.02). Aborted SCA was not associated with a greater mean QTc duration, Tpeak-Tend interval, T-wave duration, or Tpe/QT ratio. Multivariate analysis (adjusting for cardinal HCM SCA-risk factors) showed T-wave amplitude in Lead V2 was an independent predictor of risk (adjusted HR per 0.1 mV 0.74, 95% CI 0.57 to 0.97, p=0.03). Addition of T-wave amplitude in Lead V2 to the traditional risk factors resulted in significant improvement in risk stratification (C-statistic from 0.65 to 0.75) but did not improve the performance of the HCM SCD-risk score. Conclusions T-wave amplitude is a novel marker of SCA in this high risk HCM population and may provide incremental predictive value to established risk factors. Further work is needed to define the role of repolarisation abnormalities in predicting SCA in HCM.
Optimally predicting mortality with kidney function markers is not the same as optimally determining how kidney function predicts mortality
Glassock, Richard J. , Rule, Andrew D.

Nephrology Dialysis Transplantation | February 24, 2017 | Volume: 32 | Issue: 4 | Pages: 585-587

10.1093/ndt/gfx007 | PMID 28339938 Get It

Diagnosis of a malignant adrenal mass: the role of urinary steroid metabolite profiling
Bancos, Irina , Arlt, Wiebke , Bancos, Irina , Arlt, Wiebke

Current Opinion in Endocrinology, Diabetes & Obesity | February 24, 2017 | Volume: 24 | Issue: 3 | Pages: 200-207

10.1097/med.0000000000000333 | PMID 28234802 Get It

Purpose of review Adrenal masses are highly prevalent, found in 5% of the population. Differentiation of benign adrenocortical adenoma from adrenocortical carcinoma is currently hampered by the poor specificity and limited evidence base of imaging tests. This review summarizes the results of studies published to date on urine steroid metabolite profiling for distinguishing benign from malignant adrenal masses. Recent findings Three studies have described cohorts of at least 100 patients with adrenal tumors showing significant differences between urinary steroid metabolite excretions according to the nature of the underlying lesion, suggesting significant value of steroid metabolite profiling as a highly accurate diagnostic test. Summary Steroid profiling is emerging as a powerful novel diagnostic tool with a significant potential for improving the management for patients with adrenal tumors. Although the current studies use gas chromatography–mass spectrometry for proof of concept, widespread use of the method in routine clinical care will depend on transferring the approach to high-throughput tandem mass spectrometry platforms. The use of computational data analysis in conjunction with urine steroid metabolite profiling, that is, steroid metabolomics, adds accuracy and precision.
Evaluation of a revised indication for determining adult cochlear implant candidacy
Sladen, Douglas P. , Gifford, René H. , Haynes, David S. , Kelsall, David C., Benson, Aaron G., Zwolan, Teresa A. , Gantz, Bruce J. , Gilden, Jan, Westerberg, Brian D. , Gustin, Cindy, Driscoll, Colin L. W., Driscoll, Colin L., Lewis, Kristen, Fu, Qian‐Jie , O’Neil, Lori Ross

The Laryngoscope | February 24, 2017 | Volume: 127 | Issue: 10 | Pages: 2368-2374

10.1002/lary.26513 | PMID 28233910 Get It

ObjectiveTo evaluate the use of monosyllabic word recognition versus sentence recognition to determine candidacy and long‐term benefit for cochlear implantation.Study DesignProspective multi‐center single‐subject design.MethodsA total of 21 adults aged 18 years and older with bilateral moderate to profound sensorineural hearing loss and low monosyllabic word scores received unilateral cochlear implantation. The consonant‐nucleus‐consonant (CNC) word test was the central measure of pre‐ and postoperative performance. Additional speech understanding tests included the Hearing in Noise Test sentences in quiet and AzBio sentences in +5 dB signal‐to‐noise ratio (SNR). Quality of life (QoL) was measured using the Abbreviated Profile of Hearing Aid Benefit and Health Utilities Index.ResultsPerformance on sentence recognition reached the ceiling of the test after only 3 months of implant use. In contrast, none of the participants in this study reached a score of 80% on CNC word recognition, even at the 12‐month postoperative test interval. Measures of QoL related to hearing were also significantly improved following implantation.ConclusionResults of this study demonstrate that monosyllabic words are appropriate for determining preoperative candidate and measuring long‐term postoperative speech recognition performance.Level of Evidence2c. Laryngoscope, 127:2368–2374, 2017